Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatic cancer].

M Kako1

  • 1Dept. of Medicine, Teikyo University Hospital at Mizonokuchi.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Evaluating chemotherapy

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical challenges of nurses related COVID-19 pandemic in inpatient wards: An integrative review.

Ethics, medicine, and public health·2021
Same author

Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C.

Autoimmunity·2001
Same author

CYP2D6 polymorphism and the presence of anti-LKM-1 in patients with chronic hepatitis C.

Biochemical and biophysical research communications·2000
Same author

Indirect evidence of TTV replication in bone marrow cells, but not in hepatocytes, of a subacute hepatitis/aplastic anemia patient.

Journal of medical virology·2000
Same author

Vanishing bile duct syndrome associated with chronic EBV infection.

Digestive diseases and sciences·2000
Same author

Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats.

Endocrine journal·2000
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Area of Science:

  • Oncology
  • Hepatology
  • Medical Imaging

Background:

  • Assessing chemotherapy efficacy in liver cancer is complex.
  • Existing methods face challenges in accurately measuring treatment response.
  • Standardized evaluation protocols are needed for reliable outcomes.

Purpose of the Study:

  • To identify and discuss key challenges in evaluating the antitumor effects of chemotherapy for hepatic cancer.
  • To highlight limitations in current assessment methodologies.

Main Methods:

  • Review of existing literature and clinical practices.
  • Analysis of common difficulties encountered during chemotherapy evaluation.
  • Discussion of specific problematic areas: tumor biopsy, liver cirrhosis complications, tumor size measurement errors, internal tumor changes, and Alpha-fetoprotein (AFP) level interpretation.

Related Experiment Videos

Main Results:

  • Tumor biopsy poses risks and may not represent the entire tumor.
  • Liver cirrhosis complicates accurate tumor assessment.
  • Measurement errors and difficulties in evaluating internal tumor changes hinder response assessment.
  • Reliance on Alpha-fetoprotein (AFP) alone can be misleading.

Conclusions:

  • Accurate evaluation of chemotherapy for liver cancer requires addressing multiple methodological challenges.
  • Improved techniques and standardized criteria are essential for reliable assessment of treatment effectiveness.
  • Multifaceted approaches are necessary to overcome current limitations in evaluating hepatic cancer chemotherapy.